(Q30370190)

21 June 2017

Favipiravir: a new medication for the Ebola virus disease pandemic. (English)

1 reference

21 June 2017

0 references

Ebola hemorrhagic fever

0 references

Orthoebolavirus zairense

0 references

0 references

Alan K Lefor

2

0 references

author name string

Takashi Nagata

series ordinal

1

1 reference

PubMed ID

25544306

21 June 2017

Manabu Hasegawa

series ordinal

3

1 reference

PubMed ID

25544306

21 June 2017

Masami Ishii

series ordinal

4

1 reference

21 June 2017

29 December 2014

1 reference

Disaster Medicine and Public Health Preparedness

21 June 2017

1 reference

21 June 2017

9

1 reference

21 June 2017

1

1 reference

21 June 2017

79-81

1 reference

Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.

21 June 2017

1 reference

https://api.crossref.org/works/10.1017%2FDMP.2014.151

Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FDMP.2014.151

Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FDMP.2014.151

Ebola virus disease in the Democratic Republic of Congo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FDMP.2014.151

Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FDMP.2014.151

21 January 2018

Identifiers

DOI

10.1017/DMP.2014.151

1 reference

21 June 2017

1 reference

PubMed ID

25544306